Clinical Trial Update: ALT-801 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus (T2DM) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of ALT-801 in overweight and obese adults with Type 2 diabetes mellitus has completed dosing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ALT-801

Snippet

Sponsor: Altimmune, Inc. | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED